182 related articles for article (PubMed ID: 36356279)
1. Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer.
Culakova E; Mohile SG; Peppone L; Ramsdale E; Mohamed M; Xu H; Wells M; Tylock R; Java J; Loh KP; Magnuson A; Jamieson L; Vogel V; Duberstein PR; Chapman BP; Dale W; Flannery MA
J Clin Oncol; 2023 Feb; 41(4):835-846. PubMed ID: 36356279
[TBL] [Abstract][Full Text] [Related]
2. An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Xu H; Mohamed M; Flannery M; Peppone L; Ramsdale E; Loh KP; Wells M; Jamieson L; Vogel VG; Hall BA; Mustian K; Mohile S; Culakova E
JAMA Netw Open; 2023 Mar; 6(3):e234198. PubMed ID: 36947036
[TBL] [Abstract][Full Text] [Related]
3. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
Presley CJ; Mohamed MR; Culakova E; Flannery M; Vibhakar PH; Hoyd R; Amini A; VanderWalde N; Wong ML; Tsubata Y; Spakowicz DJ; Mohile SG
Front Oncol; 2022; 12():835582. PubMed ID: 35433441
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.
Mohile SG; Mohamed MR; Xu H; Culakova E; Loh KP; Magnuson A; Flannery MA; Obrecht S; Gilmore N; Ramsdale E; Dunne RF; Wildes T; Plumb S; Patil A; Wells M; Lowenstein L; Janelsins M; Mustian K; Hopkins JO; Berenberg J; Anthony N; Dale W
Lancet; 2021 Nov; 398(10314):1894-1904. PubMed ID: 34741815
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.
Jensen-Battaglia M; Lei L; Xu H; Kehoe L; Patil A; Loh KP; Ramsdale E; Magnuson A; Kleckner AS; Wildes TM; Lin PJ; Mustian KM; Giri G; Whitehead M; Bearden J; Burnette BL; Geer J; Mohile SG; Dunne RF
JAMA Netw Open; 2022 Mar; 5(3):e223039. PubMed ID: 35302628
[TBL] [Abstract][Full Text] [Related]
7. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.
Mohile SG; Epstein RM; Hurria A; Heckler CE; Canin B; Culakova E; Duberstein P; Gilmore N; Xu H; Plumb S; Wells M; Lowenstein LM; Flannery MA; Janelsins M; Magnuson A; Loh KP; Kleckner AS; Mustian KM; Hopkins JO; Liu JJ; Geer J; Gorawara-Bhat R; Morrow GR; Dale W
JAMA Oncol; 2020 Feb; 6(2):196-204. PubMed ID: 31697365
[TBL] [Abstract][Full Text] [Related]
8. Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
Li D; Sun CL; Kim H; Soto-Perez-de-Celis E; Chung V; Koczywas M; Fakih M; Chao J; Cabrera Chien L; Charles K; Hughes SFDS; Katheria V; Trent M; Roberts E; Jayani R; Moreno J; Kelly C; Sedrak MS; Dale W
JAMA Oncol; 2021 Nov; 7(11):e214158. PubMed ID: 34591080
[TBL] [Abstract][Full Text] [Related]
9. Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.
Kleckner AS; Wells M; Kehoe LA; Gilmore NJ; Xu H; Magnuson A; Dunne RF; Jensen-Battaglia M; Mohamed MR; O'Rourke MA; Vogelzang NJ; Dib EG; Peppone LJ; Mohile SG
JCO Oncol Pract; 2022 Jan; 18(1):e9-e19. PubMed ID: 34228510
[TBL] [Abstract][Full Text] [Related]
10. Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study.
Magnuson A; Lemelman T; Pandya C; Goodman M; Noel M; Tejani M; Doughtery D; Dale W; Hurria A; Janelsins M; Lin FV; Heckler C; Mohile S
Support Care Cancer; 2018 Feb; 26(2):605-613. PubMed ID: 28914366
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.
Dueck AC; Scher HI; Bennett AV; Mazza GL; Thanarajasingam G; Schwab G; Weitzman AL; Rogak LJ; Basch E
JAMA Oncol; 2020 Feb; 6(2):e193332. PubMed ID: 31556911
[TBL] [Abstract][Full Text] [Related]
12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
13. Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer.
Mohamed MR; Rich DQ; Seplaki C; Lund JL; Flannery M; Culakova E; Magnuson A; Wells M; Tylock R; Mohile SG
JAMA Netw Open; 2024 Feb; 7(2):e2356106. PubMed ID: 38358742
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.
Gilmore N; Xu H; Kehoe L; Kleckner AS; Moorthi K; Lei L; Mohamed MRS; Loh KP; Culakova E; Flannery M; Ramsdale E; Duberstein PR; Canin B; Kamen C; Giri G; Watson E; Patil A; Onitilo AA; Burnette B; Janelsins M; Mohile SG
Cancer; 2022 Mar; 128(5):1101-1109. PubMed ID: 34762734
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
Basch E; Pugh SL; Dueck AC; Mitchell SA; Berk L; Fogh S; Rogak LJ; Gatewood M; Reeve BB; Mendoza TR; O'Mara AM; Denicoff AM; Minasian LM; Bennett AV; Setser A; Schrag D; Roof K; Moore JK; Gergel T; Stephans K; Rimner A; DeNittis A; Bruner DW
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):409-418. PubMed ID: 28463161
[TBL] [Abstract][Full Text] [Related]
16. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
17. Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
Sandler KA; Mitchell SA; Basch E; Raldow AC; Steinberg ML; Sharif J; Cook RR; Kupelian PA; McCloskey SA
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):44-52. PubMed ID: 30102201
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy.
King-Kallimanis BL; Kanapuru B; Blumenthal GM; Theoret MR; Kluetz PG
Semin Oncol; 2018 Aug; 45(4):201-209. PubMed ID: 30482633
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment.
Mohamed MR; Kyi K; Mohile SG; Xu H; Culakova E; Loh KP; Flannery M; Obrecht S; Ramsdale E; Patil A; Dunne RF; DiGiovanni G; Hezel A; Burnette B; Desai N; Giguere J; Magnuson A
J Geriatr Oncol; 2021 Nov; 12(8):1208-1213. PubMed ID: 34272204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
